Teva usa 2025
Teva usa 2025
Teva usa 2025
Teva usa 2025
Teva usa 2025
Teva usa 2025

Teva usa 2025

Teva usa 2025, Teva Pharmaceutical Statistics Facts Revenue Subsidiaries 2025

$40.00

SKU: 7491395

Colour
  • Teva Pharmaceuticals USA Inc. v. Sandoz Inc. 135 S.Ct. 831
  • Helsinn Healthcare v. Teva USA Decision January 22 2019
  • Teva brings on Christine Fox to replace US commercial chief Sven
  • Teva Pharmaceuticals at heart of major price fixing suit in US
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus